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The  study  of  mitochondrial biogenesis has  been 
greatly advanced by the isolation and characteriza- 
tion of various mutants of mitochondrial function. 
Genetic analysis of such mutants led to the demon- 
stration of non-Mendelian inheritance and of re- 
combination of cytoplasmic genetic characteristics 
which  are considered to  reside  on mitochondrial 
DNA (mtDNA) (for reviews see !-5). Most of this 
work  has  utilized Saccharomyces cerevisiae, al- 
though Paramecium (6) and Neurospora (7) have 
been  used  in  similar  studies.  It  has  been  only 
recently, however, that mutants of mitochondrial 
function in  mammalian cells have  been isolated 
(8-10). 
The  selection  of  chloramphenicol-resistant 
mammalian cells  by  Eisenstadt  and  co-workers 
(8-10)  was  done  in  the  presence  of  ethidium 
bromide and chloramphenicol. This technique al- 
lowed for the selection of cells which were resistant 
to chloramphenicol at the level of isolated mito- 
chondrial protein synthesis (8)  and whose  resist- 
ance was a cytoplasmic characteristic (10). Mam- 
malian cells  resistant to  ethidium bromide have 
also  been  reported  (11),  but  the  nature  of  this 
resistance  is  not  known.  Studies  of  mutants of 
mitochondrial function are  necessary for  further 
elucidation  of  the  nature  and  function  of  the 
mitochondrial genetic system in mammalian cells. 
This  kind  of  genetic  approach  needs  a  readily 
available method for the selection of mammalian 
cells with altered mitochondrial function. 
The thymidine kinase-deficient mouse cell  line 
LMTK- (12) has been shown to contain a thymi- 
dine kinase activity associated with the mitochon- 
dria (13-15). This enzyme is presumably responsi- 
ble  for  the  incorporation  of  [SH]thymidine  or 
5-bromodeoxyuridine  (BUdR)  (13)specifically 
into  the  mtDNA  of  these  cells.  The  possibility 
exists  that  specific  incorporation of  BUdR  into 
mtDNA may result in mutations of the mitochon- 
drial  genome.  BUdR  has  been  shown  to  be  an 
effective mutagen in bacteriophage (16) as well as 
in animal cell viruses (17,  18). This paper describes 
the  selection and preliminary characterization of 
LMTK- cells resistant to Tevenel (E. I. DuPont de 
Nemours  &  Co.,  Inc.,  Wilmington, Del.),  the 
sulfamoyl  analog  of  chloramphenicol  (19,  20). 
Tevenel, a specific  inhibitor of mitochondrial pro- 
tein synthesis, has  been shown previously in this 
laboratory (21-24) to have lesser side effects  than 
o-chloramphenicol,  resulting  in  a  more  specific 
effect when applied to the growth of mammalian 
cells in culture (20). 
METHODS 
Growth and Maintenance of Cell Cultures 
The LMTK- cell line, originally derived by Kit et al. 
(12),  was  obtained  from Dr.  B.  L.  Hillcoat  of  the 
Department of Biochemistry,  McMaster University. The 
cells were maintained in suspension culture in a mini- 
mum essential medium (Joklik's  modification) supple- 
mented  with 5%  fetal calf  serum as  previously de- 
scribed (20). Cells resistant to Tevenel were also main- 
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tained 100 #g Tevenel/ml as well (see below). 
Selection  of Cells Resistant  to  Tevenel 
Initial experiments were designed to use  BUdR as a 
specific mutagen of mtDNA in the LMTK- cell line. In 
the  course  of these  experiments it  was  found  that  a 
significant  proportion  of the  LMTK- cell  population 
could be selected  for resistance to Tevenel without prior 
BUdR treatment. BUdR was found not to increase the 
yield of resistant cells in the uncloned  LMTK- cell line. 
The  possible  reasons  for  this  lack  of  effect  will  be 
discussed below.  This paper deals with ceils resistant to 
Tevenel selected without previous treatment with BUdR. 
LMTK-  cells  growing  in  suspension  culture  were 
treated for 5 days with  1130 #g Tevenel/ml. At the end of 
the  5-day  treatment  the  cells  had  essentially stopped 
growing  (cf.  Fig.  1).  The  cells  were then  plated  onto 
100-mm  Petri  dishes  and  maintained  in  a  minimum 
essential medium (Eagle's) supplemented with 10% fetal 
calf serum  and  100  ag  Tevenel/ml. The  medium was 
changed frequently since  it became very  acidic as cells 
died off. As a control, mouse L cells were treated in an 
identical manner. After 2 wk of growth in Tevenel,  the 
LMTK-  cell  line  yielded  approximately  80  resistant 
clones from the 5 ￿  105 cells plated, while the L-cell line 
yielded none. The  Petri dishes containing the resistant 
LMTK  cells  were  allowed  to  grow  to  confluence, 
harvested, and clones selected as described by Puck et al. 
(25).  Three of these clones (denoted T2,  T8,  and T22) 
were chosen for analysis. 
Measurement  of Cell Growth 
Cell  growth  in  the presence and  absence of  100 jag 
Tevenel/ml  was  measured  in  suspension  cultures  of 
LMTK-  or  Tevenel-resistant cells  as  described previ- 
ously (26). 
To  determine whether the cells  resistant to Tevenel 
retained their thymidine kinase deficiency,  the ability  of 
the  cells  to  grow  in  (a)  a  minimum essential medium 
(Eagle's) supplemented with  10%  fetal calf serum  and 
25  ag  BUdR per ml  (12),  or (b)  HAT  medium (10  -~ 
M  hypoxanthine, 5  x  10  -5 M  thymidine, and  10 -6 M 
methotrexate)  (27)  was  examined.  Cells  deficient  in 
thymidine kinase are able to grow in 25 t~g BUdR per ml 
(12) but not in HAT medium (27). 
Measurement  of Relative  Plating Efficiency 
Plating efficiency  of LMTK  or  resistant cells  was 
determined by scoring the number of clones formed on 
plates  inoculated  with  200  cells.  The  absolute  plating 
efficiency  was  variable  but  usually  in  the  range  of 
70-90%.  The  relative  plating  efficiency  is  reported  in 
order to make the results comparable from experiment to 
experiment and from cell type to cell type. 
Measurement  of Protein Synthesis  by 
Isolated Mitochondria 
Mitochondria were isolated from 2 ￿  108 cells essen- 
tially  as  described  by  Constantino  and  Attardi  (28), 
except that the cells were washed and disrupted in 0.3 M 
sucrose,  2 mM EDTA, 2 mM Tris-HCI, pH 7.4, with an 
Ultra-Turrax homogenizer as described previously  (29). 
Mitochondrial protein synthesis was measured by incu- 
bating the mitochondrial fraction at 30~  in a medium 
(30) which contained 1-2 mg protein/ml, 50 mM KCI, 20 
mM  potassium  phosphate,  5  mM  MgCI~, 100  mM 
sucrose, 10 mM sodium succinate,  2 mM ADP, 0.1 mM 
in all the amino acids except leucine,  300 #g cyclohexi- 
mide/ml  (28),  and  17  #Ci  L-[4,5-SH]leucine  (53  Ci/ 
mmol)/ml, pH 7.2. At time intervals from 0 to 60 min, 
0.05-ml  samples  were  removed,  put  onto  Whatmann 
3MM filter disks, and then into 5% trichloroacetic acid 
containing 1 mg unlabeled  leucine/ml. At the end of the 
incubations, the disks were boiled  for 20 rain  in the 5% 
trichloroacetic acid  containing leucine and then washed 
at  0~  twice  with  5%  trichloroacetic acid,  once with 
50:50 ethanol-ether, and once with ether (31). The filter 
paper disks were then dried and counted with a toluene- 
based  scintillation  fluid  in  a  Nuclear-Chicago Mark  1 
scintillation  spectrophotometer  (Nuclear Chicago Corp., 
Des Plaines, Ill.). The effect of increasing concentrations 
of Tevenel or D-chlorampbenicol on mitochondrial pro- 
tein synthesis was determined in a 30-rain incubation. In 
experiments designed to determine the effect of Triton 
X-100 on mitochondrial protein synthesis, the incubation 
medium was modified. ADP and succinate were replaced 
with  10 mM phosphoenolpyruvate, 2 mM ATP, and 25 
t~g  pyruvate  kinase  per  ml,  and  the  incubations were 
performed in the presence of 0.01% Triton X-100 (8). The 
incorporation  obtained  was  approximately  100,000 
cpm/mg protein/30 min. Protein was determined by the 
method of Lowry et al. (32). 
MATERIALS 
Tevenel  was  a  gift  from  Dr.  C.  E.  Hoffmann,  E.  I. 
Du  Pont de Nemours & Co.,  Inc.,  Stine Laboratories, 
Newark,  Del.;  D-chloramphenicol  and L-chlorampbeni- 
col  were  gifts  from  Parke,  Davis  &  Co.,  Research 
Division,  Detroit,  Mich.  Cycloheximide,  5-bromo-2'- 
deoxyuridine, and  Triton  X-100  were  purchased  from 
Sigma Chemical Co., St. Louis,  Mo. Phosphoenolpyru- 
vate and pyruvate kinase were products of Calbiocbem, 
La  Jolla,  Calif.  ATP  was purchased from  Boehringer 
Mannbeim Corp., New York, and ADP from P-L Bid- 
chemicals, Milwaukee,  Wis.  All tissue culture supplies 
were  purchased  from  Grand  Island  Biological  Co., 
Grand Island, N. Y. L-[4,5-3H]leucine was a product of 
Amersham/Searle Corp.,  Arlington  Heights,  111. The 
source  of hypoxanthine,  thymidine,  and  methotrexate 
(HAT medium) is as described previously (26). 
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Growth Characteristics of Resistant Cells 
The growth of three Tevenel-resistant cell lines 
(T2,  T8,  and  T22)  were  compared  with  that  of 
LMTK-  in  the  presence  and  absence  of  100 #g 
Tevenel/ml.  Typical growth  curves  for  LMTK- 
(A) and T8 (B) are shown in Fig. 1. While LMTK- 
ceases to grow in 100 gg Tevenel/ml, T8 continues 
to grow at the same rate in the presence or absence 
of Tevenel. The same result was obtained for both 
T2  and  T22.  The  resistant  cell  lines  have  been 
maintained  for  many  weeks  in  the  presence  of 
Tevenel  without  any  apparent  effect  on  cell 
growth. 
To  determine  whether  the  resistant cells were 
cross-resistant to D-chioramphenicol, relative plat- 
ing efficiencies were determined. In Table I, it can 
be seen that T8 and T22 plate efficiently in  100 gg 
Tevenel/ml  and  50  #g  D-chloramphenicol/ml, 
while  no  clones are  observed  for  LMTK-  under 
these  conditions.  The  slightly lower  plating effi- 
ciency of the resistant cells in D-chloramphenicol 
may not be due to a specific effect of the chloram- 
phenicol on mitochondrial protein synthesis, since 
a lower efficiency is also seen in the presence of 50 
#g  L-chloramphenicol/ml for T8 and T22 as well 
as LMTK-. L-Chloramphenicol is not effective in 
inhibiting mitochondrial protein synthesis but it, as 
well as D-chloramphenicol, inhibits respiration as 
described previously (21-24). 
The  stability of the change  responsible for the 
resistance of these cells was examined by compar- 
ing the relative plating efficiencies in the presence 
and  absence of 100 gg Tevenel/ml. A  culture of 
T22 grown for more than  100 days in the absence 
of  Tevenel  (about  100  generations)  plated  with 
similar efficiencies in the presence and absence of 
Tevenel,  as  did  a  culture  of T22  maintained  in 
Tevenel for more than  1 mo (Table II). This result 
suggests that  the  change  responsible for Tevenel 
TABLE  1 
Effect of Chloramphenicol Analogs on the Relative 
Plating Efficiencies of LMTK-, T8, and T22 
Relative plating efficiency 
Drug  LMTK  T8  T22 
None  1.00•  1.00•  1.00 •  0.()5 
Tevenel  0  0.96 •  0.08  0.87 •  0.07 
D-Chloram-  0  0.74 •  0.08  0.68 •  0.08 
phenicol 
L-Chloram-  0.71 •  0.07  0.86 •  0.13  0.78 •  0. l 1 
phenicol 
Relative  plating  efficiency  was  determined  as  described  in 
Methods. The concentration of Tevenel  is  100 ~g/ml,  and the 
concentration of L- and o-chloramphenicol is 50/~g/ml. 
The  errors  indicate  standard  deviation.  The  absolute  plating 
efficiencies in tl~e absence of drug were 76%, 78%, and 68% for 
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FIGURE  I  Growth curves of LMTK-  cells (A) and T8 cells (B). Growth measurements were performed on 
cells growing in suspension culture as described previously (19). Each cell count is the average from two 
cultures. Tevenel (100/~g/ml)  was present (O----O) or absent (O  0) during growth. 
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~--  I00 
Drug  T22 (-)*  T22 (+)~/ 
None  1.00 •  0.06  1.00 •  0.05 
Tevenel  0.92 •  0.04  0.98 •  0.13 
Relative plating efficiency was  determined as described 
in Methods. The concentration of Tevenel is 100 ~tg/ml. 
The  errors  indicate  standard  deviation.  The  absolute 
plating efficiencies  in the absence  of Tevenel were 89% 
and 78% for T22 (-) and T22 (+), respectively. 
*T22  (-)  maintained  for  100  days  in  the  absence  of 
Tevenel. 
~t T22 (+) maintained for 35 days in the presence  of 100 
jag Tevenel/ml. 
resistance is stable over the time interval examined 
and is inheritable. Similar results have been found 
for the other two resistant lines. 
The resistant  cell lines were examined for their 
ability to grow in the presence of BUdR and HAT. 
They were found to be resistant to 25 ~g BUdR/ml 
and sensitive to HAT, consistent with retention of 
the thymidine  kinase deficiency of the parent  cell 
line (LMTK-). 
M itoc  hondrial Protein Synthesis 
To determine that the growth characteristics of 
the  resistant  cells  is  not  due  to  changes  in  cell 
membrane  permeability  to  Tevenel  and  D- 
chloramphenicol,  the  effect  of  these  drugs  on 
protein  synthesis  in  isolated  mitochondria  was 
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TABLE  I1 
Stability of the Resistance  to Tevenel in T22 
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FIGURE 2  Effect  of  increasing  concentrations  of Tevenel  (A)  or  D-chioramphenicol (B)  on  protein 
synthesis  in  isolated  mitochondria  from  LMTK-  (V  V), T8  (O  O),  or T22  (Q'"'e).  Protein 
synthesis  was measured as described in Methods; incubations were carried out for 30 min at 30~  100% 
incorporation is approximately  100,000 cpm/mg protein/30 min. 
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FIGURE  3 
from LMTK- (O-me) or T22 (O 
Fig. 2. 
Effect of increasing concentrations of Tevenel on Triton X-100- (0.01%) treated m  itochondria 
O). Protein synthesis was measured as described in Methods and 
synthesis by mitochondria from both T8 and T22 
shows  a  marked  resistance to  both  Tevenel and 
D-chloramphenicol  with  respect  to  the  protein 
synthesis of LMTK- mitochondria. Although the 
resistance  is  not  complete,  similar  results  have 
been reported for chloramphenicol-resistant HeLa 
cells (8),  and for chloramphenicol-resistant yeast 
(33).  The resistance to Tevenel of the  mitochon- 
drial protein synthesis in T22 was not decreased by 
incubation in the presence of 0.01%  Triton X-100 
(Fig. 3), suggesting that the resistance is not due to 
a change in the permeability of the mitochondrial 
membranes to  the  drug (8).  Similar results were 
obtained with T8 mitochondria. 
DISCUSSION 
The  Tevenel-resistant cells  described above have 
many of the properties expected for cells carrying a 
cytoplasmic mutation. The resistance is stable; it is 
expressed  at  the  level  of  isolated  mitochondrial 
protein synthesis; it does not appear to be due to a 
lack  of permeability of the  mitochondrial mem- 
brane to Tevenel, and both cell growth and mito- 
chondrial protein synthesis are  cross-resistant to 
D-chloramphenicol. The  ultimate  proof that  the 
resistance is a mutation within the mtDNA would 
be to demonstrate cytoplasmic inheritance of the 
characteristic,  as  has  been  shown  for  resistant 
mouse A9 cells by Bunn et al. (10).  Experiments 
along this line are now in progress. 
The ease with which  Tevenel-resistant cells can 
be isolated from an LMTK- population may make 
this  cell  line  useful  for  the  isolation  of  cells 
resistant to other drugs which interfere with mito- 
chondrial  function.  Isolation  of  such  mutants 
would then allow studies on recombination of the 
mammalian mitochondrial genome. Evidence that 
recombination does occur in mammalian mtDNA 
has been presented by Coon et al. (34), and Dawid 
et al. (35) studying the buoyant density of mtDNA 
in rodent-human hybrids. Hybrid cells may offer a 
convenient system for the study of recombination 
of  antibiotic-resistant  markers  in  mammalian 
mtDNA. 
The reason that BUdR was not found to stimu- 
late the production of cells resistant to Tevenel is 
not  clearly  understood.  It  is  possible  that  the 
population  of  LMTK-  cells  chosen  for  study 
contained a very high proportion of resistant cells 
due to  its prior exposure to  BUdR and that this 
genetic lesion  was  maintained throughout  many 
generations in the absence of the selective pressure. 
A  high  background of resistant cells  would then 
mask  any  effect  of  BUdR  in  producing  new 
mutations. It is also not known what the effect  of 
ethidium bromide was in the selection of chloram- 
phenicol-resistant cells,  as  reported  by  Spolsky 
and Eisenstadt (8). 
The selection conditions reported  here are sig- 
nificantly different from those reported by Spolsky 
and  Eisenstadt (8).  Here,  the LMTK- cells  were 
exposed  to  inhibitor for 5 days before plating in 
Tevenel.  This  treatment  was  done  in  order  to 
inhibit the growth of sensitive cells before plating, 
such that they did not overgrow the Petri dishes. 
This procedure could tend to enrich the suspension 
496  BRIEF  NOTES culture with resistant cells, and would account,  in 
part,  for  the  high  frequency  of  clones  observed 
under  these  conditions.  In  addition,  the  use  of 
Tevenel rather than chloramphenicol is significant. 
It  has  been  shown  previously  (20)  that  chloram- 
phenicol  is  more  inhibitory  than  Tevenel  on  the 
growth of cells in culture. This effect is probably a 
result  of the  inhibition  of respiration  (21  24),  or 
perhaps  of DNA synthesis  (36)  by chiorampheni- 
col.  It  may  be  more  difficult, therefore,  to  select 
for  cells  resistant  to  chloramphenicol  than  to 
Tevenel. These differences in  selection conditions 
may account  for the failure of Bunn et al. (10) to 
observe chloramphenicoi-resistant  LMTK-  cells. 
SUMMARY 
This study describes the selection and preliminary 
characterization  of mammalian  cells  resistant  to 
100 gg Tevenel/ml. Tevenel, the sulfamoyl analog 
of  chloramphenicol,  is  a  specific  inhibitor  of 
mitochondrial  protein  synthesis. 
After growth in suspension  culture for 5 days in 
100  ~tg Tevenel/ml and  subsequent  plating in  100 
~g  Tevenel/ml,  LMTK-  cells  yielded  resistant 
clones.  As  a  control,  L  cells  treated  identically 
yielded  no  clones.  Three  resistant  clones  were 
chosen  for  study.  Each  resistant  cell line  had  an 
identical growth  rate  in the presence  and  absence 
of 100 ttg Tevenel/ml. By plating efficiency analy- 
sis, the resistant cells were found to be cross-resist- 
ant to D-chloramphenicol. The change responsible 
for  resistance  was  found  to  be  stable  for at  least 
100  generations in the absence  of the drug. 
Protein  synthesis  by  isolated  mitochondria  of 
resistant  cells  was  found  to  be  less  inhibited  by 
concentrations  of  both  Tevenel  and  D-chloram- 
phenicol up to 200/~g/ml than the protein synthe- 
sis  by  LMTK-  mitochondria.  This  resistance  in 
vitro was not changed  by incubation  of the mito- 
chondria  in 0.01% Triton X-100. 
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